home

6. Networking & Business Development Forum on September 15th


For the sixth time in a row we invite high executives from Pharma and Biotech companies to meet and to build up their network.

http://www.binder-associates.de/business.html

_________________________________________________________________________________

Join us at BioEurope


for our panel session addressing a crucial success factor in our industry on

Monday 15 November 2010, 9:00–10:30 am


Workshop CMO-Biotech Partnerships: Evaluating Different Business Models


Financing of biopharmaceutical process development and manufacturing as "fee for service" is a major challenge for most biotechs. More and more CMOs offer alternative business models such as mix of "fee for service" with project specific investment or reduced fees in combination with technology licenses or option on later licensing rights. But what should you consider when a pernership with a CMO goes beyond the conventional way? Opportunity or trap? The panel will discuss the characteristics of the individual models, the risks and benefits and will clarify the questions you always wanted to ask.

Moderator:
    Klaus Binder

Speakers at BioEurope:
    Jochen Alberstetter, Vetter Pharma-Fertigung GmbH & Co. KG
    Uwe Bücheler Boehringer Ingelheim
    Fritjof Linz, DSM Biologics
    Klaus B. Schoepe, Rentschler Biotechnologe
    Frank Ubags, Sdil Proteins
    Thomas G. Wellner, Therapure Biopharma


Binder Associates GmbH · Hinterer Anger 338 A · 86899 Landsberg am Lech · Germany · ++49.(0)8191.9856.335